<DOC>
	<DOCNO>NCT01659320</DOCNO>
	<brief_summary>This research study examine whether elderly depressed patient whose depressive symptom respond satisfactorily therapy mood stabilizer antidepressant alone gain benefit take minocycline alone addition antidepressant mood stabilizer medication . Minocycline commonly use antibiotic medication anti-inflammatory property . It hop information gain study help investigator well understand role inflammation depression , whether decrease inflammation lead improvement symptom depression cognitive function .</brief_summary>
	<brief_title>Open Treatment Minocycline Geriatric Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>1 . Age : Participants must 55 year old old ( female patient must postmenopausal ) ; 2 . Diagnosis : Major depression , either unipolar bipolar without psychotic feature ( Diagnostic Statistical Manual Mental Disorders ( DSM ) IV criterion assess Structured Clinical Interview Diagnostic Statistical Manual Mental Disorders ( SCID ) ; 3 . Severity depression : 17item Hamilton Depression Rating Scale ( HRSD ) &gt; 14 ; 4 . Failure achieve substantial improvement depressive symptom ( entry HDRS &gt; 14 ) least 6 week treatment mood stabilizer antidepressant ( SSRI , SNRI , TCA ) reach therapeutic dosage ( daily dose least : fluoxetine 20 mg , sertraline 150 mg , paroxetine 20 mg , citalopram 20 mg , escitalopram 10 mg , venlafaxine 150 mg , duloxetine 60 mg ) . 5 . Fluency English 6 . Capacity provide informed consent . 1 . High suicide risk , i.e . intent plan attempt suicide near future ; 2 . Presence current Axis I psychiatric disorder ( unipolar bipolar major depression generalize anxiety disorder ) include substance abuse ( history substance abuse must abstinent least 3 month prior entry ) ; 3 . Axis II diagnosis antisocial personality disorder , schizotypal severe borderline personality , mental retardation pervasive developmental disorder ( DSMIV ) ; 4 . Dementia mild severity ( MMSE &lt; 20 ) ; 5 . History psychiatric disorder psychotic depression , primary psychotic disorder 6 . Acute severe medical illness , i.e. , delirium , metastatic cancer , decompensated cardiac , liver kidney failure , major surgery , stroke myocardial infarction three month prior entry , advance autoimmune deficiency , `` end stage '' chronic obstructive pulmonary disease ; drug know cause depression , e.g. , reserpine , alphamethyldopa , steroid , sympathomimetics withdrawal ; 7 . Presence significant neurological disease Parkinson 's disease , primary secondary seizure disorder , intracranial tumor , severe head trauma ; neurodegenerative disease i.e . Multiple Sclerosis ; 8 . History intolerance minocycline tetracycline ; use concomitant drug may provide reason believe minocycline contraindicate ; 9 . Patients anticoagulant ( except lowdose aspirin ) ; patient ergot alkaloid 10 . Patients MAOIs ; 11 . Patients ' unwillingness inability gradually withdraw psychotropic medication ( except follow : Antidepressants , mood stabilizer , low stable dos opiates nonbenzodiazepine hypnotic , e.g . zolpidem ( 5 10 mg ) , zaleplon ( 5 10 mg ) . 12 . Inability perform ADLs ( MAI : ADL subscale ) even assistance , e.g . walk cane exclusion criterion ; 13 . Inability speak English ; 14 . Corrected visual acuity &lt; 20/70 ;</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>